Agios Pharmaceuticals Inc (AGIO)

34.19 -1.16 (-3.28%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Agios Pharmaceuticals Max Drawdown (5Y): 82.86% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for AGIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Haemonetics Corp 68.62%
Pfizer Inc 54.78%
ResMed Inc 53.98%
Twist Bioscience Corp 94.48%
Arcellx Inc --

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -4.239
Beta (5Y) 0.7982
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 51.20%
Historical Sharpe Ratio (5Y) 0.1254
Historical Sortino (5Y) 0.2311
Monthly Value at Risk (VaR) 5% (5Y Lookback) 22.26%